Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 4 boards, counting each seat separately. Longest: Nuvation Bio Inc., 3 years.
Nuvation Bio Inc.
Director
AnaptysBio Inc.
Director
Zymeworks Inc.
Director
Aktis Oncology Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
AnaptysBio Inc. June 12, 202482.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 12, 2026 | Aktis Oncology Inc. | Derivative conversion | +2,270,879 | — | — |
| Jan 12, 2026 | Aktis Oncology Inc. | Derivative conversion | +202,862 | — | — |
| Jan 12, 2026 | Aktis Oncology Inc. | Derivative conversion | +128,506 | — | — |
| Jan 12, 2026 | Aktis Oncology Inc. | Open-market purchase | +2,077,779 | $18.00 | $37,400,022 |
| Jan 12, 2026 | Aktis Oncology Inc. | Open-market purchase | +144,443 | $18.00 | $2,599,974 |
| Jun 26, 2025 | Zymeworks Inc. | In-the-money exercise | +5,086,480 | — | — |
| Jun 26, 2025 | Zymeworks Inc. | Shares withheld for tax | −41 | $12.71 | $521 |
| Apr 4, 2025 | Zymeworks Inc. | Open-market purchase | +196,438 | $11.17 | $2,194,212 |
| Apr 3, 2025 | Zymeworks Inc. | Open-market purchase | +120,770 | $11.84 | $1,429,917 |
| Mar 13, 2025 | Zymeworks Inc. | Open-market purchase | +468,356 | $12.48 | $5,845,083 |
| Mar 12, 2025 | Zymeworks Inc. | Open-market purchase | +292,934 | $12.25 | $3,588,442 |
| Mar 11, 2025 | Zymeworks Inc. | Open-market purchase | +320,690 | $11.49 | $3,684,728 |
| Feb 21, 2023 | Nuvation Bio Inc. | Open-market purchase | +53,000 | $1.36 | $72,080 |
| Feb 20, 2023 | Nuvation Bio Inc. | Open-market purchase | +117,100 | $1.36 | $159,256 |
| Feb 19, 2023 | Nuvation Bio Inc. | Open-market purchase | +5,143,000 | $1.26 | $6,480,180 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.